These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24801454)

  • 1. [Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
    Molderings GJ; Homann J; Brettner S; Raithel M; Frieling T
    Dtsch Med Wochenschr; 2014 Jul; 139(30):1523-34; quiz 1535-8. PubMed ID: 24801454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic mastocytosis--definition of an internal disease].
    Homann J; Kolck UW; Ehnes A; Frieling T; Raithel M; Molderings GJ
    Med Klin (Munich); 2010 Aug; 105(8):544-53. PubMed ID: 20824412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic mastocytosis. Classification, symptoms, therapy].
    Kraemer DM; Grunewald SM; Kolb-Mäurer A
    Med Klin (Munich); 2004 Mar; 99(3):131-6. PubMed ID: 15024485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
    Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis: current classification and novel therapeutic options.
    Barbie DA; Deangelo DJ
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):768-75. PubMed ID: 17099633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
    Ustun C; Savage NM; Gotlib J; Bhalla K; Manaloor E; George TI
    Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
    Falleti J; Borgia L; Lalinga AV; De Cecio R; Natella V; Patitucci G; Vita G
    Pathol Res Pract; 2012 Nov; 208(11):683-6. PubMed ID: 22963840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mastocytosis.
    George TI; Horny HP
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):1067-83, vii. PubMed ID: 22054735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis].
    Gülen T; Gottberg L; Dahlén B; Nilsson G; Hägglund H
    Lakartidningen; 2012 Feb 29-Mar 13; 109(9-10):474-7. PubMed ID: 22530411
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic mastocytosis].
    Metzgeroth G; Schwaab J; Reiter A
    Dtsch Med Wochenschr; 2014 Aug; 139(31-32):1572-5. PubMed ID: 25076308
    [No Abstract]   [Full Text] [Related]  

  • 14. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
    Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
    Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.
    Teodosio C; García-Montero AC; Jara-Acevedo M; Sánchez-Muñoz L; Pedreira CE; Álvarez-Twose I; Matarraz S; Morgado JM; Bárcena P; Matito A; Mayado A; Sanchez ML; Diez-Campelo M; Escribano L; Orfao A
    J Allergy Clin Immunol; 2013 Apr; 131(4):1213-24, 1224.e1-4. PubMed ID: 23403045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.